DK3294893T3 - Bioproduktion af lentivirale vektorer - Google Patents
Bioproduktion af lentivirale vektorer Download PDFInfo
- Publication number
- DK3294893T3 DK3294893T3 DK16724811.1T DK16724811T DK3294893T3 DK 3294893 T3 DK3294893 T3 DK 3294893T3 DK 16724811 T DK16724811 T DK 16724811T DK 3294893 T3 DK3294893 T3 DK 3294893T3
- Authority
- DK
- Denmark
- Prior art keywords
- bioproduction
- lentiviral vectors
- lentiviral
- vectors
- Prior art date
Links
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
- C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562161152P | 2015-05-13 | 2015-05-13 | |
| US201562161133P | 2015-05-13 | 2015-05-13 | |
| PCT/US2016/031959 WO2016183260A1 (en) | 2015-05-13 | 2016-05-12 | Bio-production of lentiviral vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3294893T3 true DK3294893T3 (da) | 2024-03-04 |
| DK3294893T5 DK3294893T5 (da) | 2024-10-07 |
Family
ID=56072458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16724811.1T DK3294893T5 (da) | 2015-05-13 | 2016-05-12 | Bioproduktion af lentivirale vektorer |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10138495B2 (da) |
| EP (2) | EP3294893B1 (da) |
| JP (3) | JP6975643B2 (da) |
| KR (1) | KR102940209B1 (da) |
| CN (1) | CN107660231A (da) |
| AU (2) | AU2016261864B2 (da) |
| CA (1) | CA2985828C (da) |
| DK (1) | DK3294893T5 (da) |
| ES (1) | ES2973118T3 (da) |
| HK (1) | HK1243730A1 (da) |
| PL (1) | PL3294893T3 (da) |
| RU (1) | RU2729385C2 (da) |
| WO (1) | WO2016183260A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3294893T3 (pl) * | 2015-05-13 | 2024-04-29 | Csl Behring Gene Therapy, Inc. | Bioprodukcja wektorów lentiwirusowych |
| CN111164211B (zh) | 2017-07-18 | 2024-08-02 | 杰特贝林基因治疗股份有限公司 | 用于治疗β-血红蛋白病的组合物和方法 |
| JP7470119B2 (ja) * | 2018-08-24 | 2024-04-17 | シーエスエル ベーリング ジーン セラピー インコーポレイテッド | 無血清培地におけるベクター産生 |
| EP3897745A1 (en) * | 2018-12-23 | 2021-10-27 | CSL Behring LLC | Haematopoietic stem cell-gene therapy for wiskott-aldrich syndrome |
| CN110684804B (zh) * | 2019-10-15 | 2023-04-18 | 上海本导基因技术有限公司 | 递送外源rnp的慢病毒载体及其制备方法 |
| EP4150097A1 (en) * | 2020-05-15 | 2023-03-22 | Ivexsol, Inc. | Compositions and methods for producing stable viral vector producer cells for cell and gene therapy |
| EP4329822A1 (en) | 2021-04-26 | 2024-03-06 | CSL Behring L.L.C. | Lentiviral vectors useful for the treatment of disease |
| EP4720100A1 (en) | 2023-05-25 | 2026-04-08 | CSL Behring LLC | Modified vectors |
| WO2025215591A1 (en) | 2024-04-12 | 2025-10-16 | Csl Behring L.L.C. | Modified vectors for xla gene therapy |
| WO2025219924A1 (en) * | 2024-04-19 | 2025-10-23 | Csl Behring Llc | Cell lines overexpressing vesicular stomatitis virus g |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000071678A1 (en) * | 1999-05-25 | 2000-11-30 | University Of Medicine And Dentistry Of New Jersey | Inducible packaging cell lines for lentivirus vectors |
| AU2003902842A0 (en) * | 2003-06-06 | 2003-06-26 | The University Of Queensland | Flavivirus replicon packaging system |
| US8293503B2 (en) * | 2003-10-03 | 2012-10-23 | Promega Corporation | Vectors for directional cloning |
| JP2006050956A (ja) * | 2004-08-11 | 2006-02-23 | Japan Science & Technology Agency | プルキンエ細胞における遺伝子の発現のための発現ベクター |
| WO2007018318A1 (ja) * | 2005-08-10 | 2007-02-15 | National University Corporation Kanazawa University | 小脳星状細胞及び／又は籠細胞特異的な遺伝子発現方法 |
| WO2007105744A1 (ja) * | 2006-03-08 | 2007-09-20 | National University Corporation Kanazawa University | プルキンエ細胞指向性ウイルスベクター |
| CN102131522A (zh) * | 2007-01-12 | 2011-07-20 | 西安大略省大学 | Hiv联合疫苗与初免加强方法 |
| WO2010075956A1 (de) * | 2008-12-16 | 2010-07-08 | C-Lecta Gmbh | Expressionsvektor |
| ES2657737T3 (es) * | 2009-07-15 | 2018-03-06 | Calimmune Inc. | Vector dual para la inhibición del virus de la inmunodeficiencia humana |
| KR20140004174A (ko) * | 2011-01-18 | 2014-01-10 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 암 치료를 위한 조성물 및 방법 |
| US20140315294A1 (en) | 2011-11-24 | 2014-10-23 | Genethon | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
| GB201202516D0 (en) * | 2012-02-13 | 2012-03-28 | Ucl Business Plc | Materials and methods relating to packaging cell lines |
| JP2013208107A (ja) * | 2012-03-02 | 2013-10-10 | Takara Bio Inc | レトロウイルスベクターの製造方法 |
| US20150329640A1 (en) * | 2012-12-20 | 2015-11-19 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
| WO2014200557A1 (en) * | 2013-06-10 | 2014-12-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of increasing the amount of fetal hemoglobin in a cell and/or mammal |
| PL3294893T3 (pl) * | 2015-05-13 | 2024-04-29 | Csl Behring Gene Therapy, Inc. | Bioprodukcja wektorów lentiwirusowych |
| CN111164211B (zh) | 2017-07-18 | 2024-08-02 | 杰特贝林基因治疗股份有限公司 | 用于治疗β-血红蛋白病的组合物和方法 |
-
2016
- 2016-05-12 PL PL16724811.1T patent/PL3294893T3/pl unknown
- 2016-05-12 ES ES16724811T patent/ES2973118T3/es active Active
- 2016-05-12 CA CA2985828A patent/CA2985828C/en active Active
- 2016-05-12 DK DK16724811.1T patent/DK3294893T5/da active
- 2016-05-12 EP EP16724811.1A patent/EP3294893B1/en active Active
- 2016-05-12 KR KR1020177034965A patent/KR102940209B1/ko active Active
- 2016-05-12 AU AU2016261864A patent/AU2016261864B2/en active Active
- 2016-05-12 EP EP23211304.3A patent/EP4316500A3/en active Pending
- 2016-05-12 HK HK18103004.8A patent/HK1243730A1/zh unknown
- 2016-05-12 CN CN201680031516.XA patent/CN107660231A/zh active Pending
- 2016-05-12 RU RU2017143141A patent/RU2729385C2/ru active
- 2016-05-12 JP JP2017559296A patent/JP6975643B2/ja active Active
- 2016-05-12 WO PCT/US2016/031959 patent/WO2016183260A1/en not_active Ceased
-
2017
- 2017-11-02 US US15/802,363 patent/US10138495B2/en active Active
-
2018
- 2018-10-18 US US16/164,178 patent/US11299752B2/en active Active
-
2021
- 2021-11-08 JP JP2021181556A patent/JP7469280B2/ja active Active
-
2022
- 2022-03-03 US US17/685,601 patent/US20220315950A1/en active Pending
- 2022-08-15 AU AU2022218478A patent/AU2022218478B2/en active Active
-
2024
- 2024-04-04 JP JP2024060681A patent/JP7833493B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20220315950A1 (en) | 2022-10-06 |
| RU2017143141A3 (da) | 2019-11-26 |
| RU2729385C2 (ru) | 2020-08-06 |
| JP7469280B2 (ja) | 2024-04-16 |
| AU2022218478A1 (en) | 2022-09-08 |
| KR20180002795A (ko) | 2018-01-08 |
| US10138495B2 (en) | 2018-11-27 |
| AU2022218478B2 (en) | 2025-02-27 |
| JP6975643B2 (ja) | 2021-12-01 |
| CA2985828A1 (en) | 2016-11-17 |
| KR102940209B1 (ko) | 2026-03-16 |
| DK3294893T5 (da) | 2024-10-07 |
| EP3294893B1 (en) | 2023-12-27 |
| CA2985828C (en) | 2020-07-14 |
| RU2017143141A (ru) | 2019-06-13 |
| US20190085359A1 (en) | 2019-03-21 |
| JP7833493B2 (ja) | 2026-03-19 |
| EP4316500A2 (en) | 2024-02-07 |
| US11299752B2 (en) | 2022-04-12 |
| ES2973118T3 (es) | 2024-06-18 |
| JP2018516557A (ja) | 2018-06-28 |
| CN107660231A (zh) | 2018-02-02 |
| JP2022043022A (ja) | 2022-03-15 |
| WO2016183260A1 (en) | 2016-11-17 |
| JP2024083457A (ja) | 2024-06-21 |
| US20180112233A1 (en) | 2018-04-26 |
| AU2016261864B2 (en) | 2022-05-26 |
| EP3294893A1 (en) | 2018-03-21 |
| AU2016261864A1 (en) | 2017-11-23 |
| PL3294893T3 (pl) | 2024-04-29 |
| EP4316500A3 (en) | 2024-04-10 |
| HK1243730A1 (zh) | 2018-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3134530T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3145949T3 (da) | Lentivirale vektorer | |
| DK3554240T3 (da) | Kombinationer af aktive forbindelser | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| EP3352472A4 (en) | RECEIVER | |
| DK3294893T3 (da) | Bioproduktion af lentivirale vektorer | |
| DK3259349T3 (da) | Dehydrogenase-katalyseret fremstilling af FDCA | |
| DK3514109T3 (da) | Hydropyrolyse af biomasseholdige råmaterialer | |
| EP3406336A4 (en) | NANO FOIL OF CORE CASE STRUCTURE TYPE | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3283210T3 (da) | Fremgangsmåde | |
| DK3474822T3 (da) | Formuleringer af brincidofovir | |
| DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| DK3113773T3 (da) | Krystallinske former af grapiprant | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| EP3354171A4 (en) | JUICER | |
| DK3368044T3 (da) | Behandling af hepatisk steatose-relateret oligo-ovulation | |
| IL246509A0 (en) | Coordinating multiple components | |
| DK3201323T3 (da) | Modificering af bakteriofag | |
| IL254502A0 (en) | Solid forms of menaquinols | |
| PT3445167T (pt) | Criopreservação de fases juvenis de perceves | |
| NO2023044I1 (no) | capromorelin | |
| DK3370881T3 (da) | Separator |